|
WO2021081345A1
|
|
Bi-peptide with affinity to extracellular matrix proteins or cells and to growth factors for tissue healing and regeneration
|
|
WO2021077081A1
|
|
Image-guided navigation system for targeted delivery of spinal cord therapies
|
|
US2021116453A1
|
|
Methods and materials for assessing and treating lichen planus
|
|
WO2021072322A1
|
|
Treatment for gastrointestinal disorders
|
|
WO2021072212A1
|
|
Proteasome inhibitors
|
|
WO2021072284A2
|
|
Canine distemper virus hemagglutinin and fusion polypeptides
|
|
WO2021067390A1
|
|
Method for optimization of orthopedic component design
|
|
WO2021062396A1
|
|
Functional ultrasound imaging for spinal cord stimulation electrode guidance and stimulation parameter optimization
|
|
WO2021062108A1
|
|
Method for modeling glenoid anatomy and optimization of asymmetric component design
|
|
WO2021055966A1
|
|
Non-metallic ultrasound-detectable markers
|
|
WO2021055767A1
|
|
Methods and materials for identifying and treating membranous nephropathy
|
|
WO2021055323A1
|
|
Spinal fixation system and kit
|
|
WO2021034710A2
|
|
Chimeric vesiculoviruses and methods of use
|
|
WO2021030655A1
|
|
Methods and materials for assessing and treating hypertensive disorders
|
|
WO2021025990A1
|
|
Tracheostomy stabilizer
|
|
WO2021021922A1
|
|
Compounds and methods for treating fibrotic pathologies
|
|
WO2021021886A1
|
|
Epidural stimulation and spinal structure locating techniques
|
|
WO2021021572A1
|
|
Antioxidant and antiviral compositions and methods
|
|
US2021022620A1
|
|
Systems, Methods and Media for Estimating Compensatory Reserve and Predicting Hemodynamic Decompensation Using Physiological Data
|
|
WO2021016164A1
|
|
Systems and methods for ultrasound attenuation coefficient estimation
|
